| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.2 |